Characteristics and outcomes of COVID-19 patients in New York City’s public hospital system

Abstract

Background New York City (NYC) bore the greatest burden of COVID-19 in the United States early in the pandemic. In this case series, we describe characteristics and outcomes of racially and ethnically diverse patients tested for and hospitalized with COVID-19 in New York City’s public hospital system. Methods We reviewed the electronic health records of all patients who received a SARS-CoV-2 test between March 5 and April 9, 2020, with follow up through April 16, 2020. The primary outcomes were a positive test, hospitalization, and death. Demographics and comorbidities were also assessed. Results 22254 patients were tested for SARS-CoV-2. 13442 (61%) were positive; among those, the median age was 52.7 years (interquartile range [IQR] 39.5–64.5), 7481 (56%) were male, 3518 (26%) were Black, and 4593 (34%) were Hispanic. Nearly half (4669, 46%) had at least one chronic disease (27% diabetes, 30% hypertension, and 21% cardiovascular disease). Of those testing positive, 6248 (46%) were hospitalized. The median age was 61.6 years (IQR 49.7–72.9); 3851 (62%) were male, 1950 (31%) were Black, and 2102 (34%) were Hispanic. More than half (3269, 53%) had at least one chronic disease (33% diabetes, 37% hypertension, 24% cardiovascular disease, 11% chronic kidney disease). 1724 (28%) hospitalized patients died. The median age was 71.0 years (IQR 60.0, 80.9); 1087 (63%) were male, 506 (29%) were Black, and 528 (31%) were Hispanic. Chronic diseases were common (35% diabetes, 37% hypertension, 28% cardiovascular disease, 15% chronic kidney disease). Male sex, older age, diabetes, cardiac history, and chronic kidney disease were significantly associated with testing positive, hospitalization, and death. Racial/ethnic disparities were observed across all outcomes. Conclusions and relevance This is the largest and most racially/ethnically diverse case series of patients tested and hospitalized for COVID-19 in New York City to date. Our findings highlight disparities in outcomes that can inform prevention and testing recommendations.

Correlation of Coagulation Parameters With Clinical Outcomes During the Coronavirus-19 Surge in New York: Observational Cohort

“…Survival in our hospitalized patients during this period was poor, with 33% of the hospitalized patients dying. This is comparable to the death rate of 28.3% for the rest of New York City during the COVID-19 peak (Filardo et al, 2020;Kalyanaraman Marcello et al, 2020;Lamb et al, 2020;Thompson et al, 2020).…”

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan

“…Variables of VIF >3 were excluded from the model; however, no variables demonstrated obvious multicollinearity. The variables included in the model were chosen based on the previous findings [18][19][20] and expert opinions. R V.3.6.3 (R core team, 2020) 21 was used for all the analyses performed in this study.…”

Impact of the COVID-19 pandemic on radiology department emergency ultrasound utilization

“…An association between male gender and COVID-19 infection, severity of disease, and hospitalization rate has been highlighted since early in the course of the pandemic [ 20 – 22 ]. A positive association between male gender and imaging utilization during the COVID pandemic has also been described [ 23 ].…”